 The company was founded in 1999 by its chief executive, Dr Daryl Ludger Fernandes.Dr Fernandes had developed glycoprofiling technology for his doctorate in the Glycobiology Institute at the University of Oxford and in the late 1980s was responsible for transfer of that technology to Oxford GlycoSciences (OGS).In 2000, the company won a UK Department of Trade and Industry (DTI) Smart award to develop biopharmaceutical glycoanalysis technology.